AXGN · Company research
Axogen, Inc. Common Stock (AXGN): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
21records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| GMED or AXGN: Which Is the Better Value Stock Right Now? | In a comparison of two medical instruments stocks, Globus Medical (GMED) and AxoGen (AXGN), both holding a Zacks Rank #2 (Buy), GMED emerges as the superior value option. GMED has a forward P/E of 15.81 compared to AXGN's 73.46, a PEG ratio of 1.27 vs 1.42, and a P/B ratio of 2.22 vs 7.47, earning GMED a Value grade of B while AXGN received an F. | View source ↗ | Zacks Investment Research | Oct 16, 2026 | neutral | 0 | 1 |
| Here's Why You Should Retain DexCom Stock in Your Portfolio for Now | DexCom (DXCM) reported strong Q2 2026 results with gross margin expanding to 64.1% and operating margin at 25.1%, driven by manufacturing efficiencies and G7 15-day product transition. However, near-term profitability could face pressure from Ireland factory ramp-up costs, forex headwinds, and higher oil-linked input costs. The company maintains a Zacks Rank #3 (Hold) rating with shares up 29.4% year-to-date. | View source ↗ | Zacks Investment Research | Oct 13, 2026 | bullish | 0.75 | 1 |
| Here's Why You Should Retain DexCom Stock in Your Portfolio for Now | DexCom (DXCM) reported strong Q2 2026 results with gross margin expanding to 64.1% and operating margin at 25.1%, driven by manufacturing efficiencies and G7 15-day product transition. However, near-term profitability could face pressure from Ireland factory ramp-up costs, forex headwinds, and higher oil-linked input costs. The company maintains a Zacks Rank #3 (Hold) rating with shares up 29.4% year-to-date. | View source ↗ | Zacks Investment Research | Oct 13, 2026 | bullish | 0.75 | 1 |
| Axogen, Inc. (AXGN) stock price, news, quote and history - Yahoo Finance Singapore | Axogen, Inc. (AXGN) stock price, news, quote and history Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Oct 9, 2026 | neutral | 0 | 0.6 |
| Axogen, Inc. (AXGN) stock price, news, quote and history - Yahoo Finance UK | Axogen, Inc. (AXGN) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 9, 2026 | neutral | 0 | 0.6 |
| Axogen (AXGN) Stock Could Be 26% Undervalued On Cash Flow Grounds - Yahoo Finance | Axogen (AXGN) Stock Could Be 26% Undervalued On Cash Flow Grounds Yahoo Finance | View source ↗ | Yahoo Finance | Oct 9, 2026 | neutral | 0 | 0.6 |
| Down 22.6% in 4 Weeks, Here's Why You Should You Buy the Dip in AxoGen (AXGN) | AxoGen (AXGN) has declined 22.6% over four weeks and is now in oversold territory with an RSI reading of 27.04, suggesting a potential reversal. Wall Street analysts have raised earnings estimates by 2.2% over the past 30 days, and the stock holds a Zacks Rank #2 (Buy) rating, indicating potential for near-term price appreciation. | View source ↗ | Zacks Investment Research | Oct 5, 2026 | bullish | 1 | 1 |
| Axogen, Inc. (AXGN) Stock Price, News, Quote & History - Yahoo! Finance Canada | Axogen, Inc. (AXGN) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 4, 2026 | neutral | 0 | 0.6 |
| Axogen Inc (AXGN) Shares Fall 6.3% -- What GF Score of 66 Tells Investors - GuruFocus | Axogen Inc (AXGN) Shares Fall 6.3% -- What GF Score of 66 Tells Investors GuruFocus | View source ↗ | GuruFocus | Oct 2, 2026 | neutral | 0 | 0.6 |
| A passive stake above 5% in Axogen (AXGN) is held through advisory clients. - Stock Titan | A passive stake above 5% in Axogen (AXGN) is held through advisory clients. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| Axogen (NasdaqCM:AXGN) Stock Forecast & Analyst Predictions - Simply Wall Street | Axogen (NasdaqCM:AXGN) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 2, 2026 | neutral | 0 | 0.6 |
| The first FDA-cleared device to repair cut nerves without stitches is now part of Axogen. - Stock Titan | The first FDA-cleared device to repair cut nerves without stitches is now part of Axogen. Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| 3 Emerging Biotech Stocks With Significant Upside Potential - MarketBeat | 3 Emerging Biotech Stocks With Significant Upside Potential MarketBeat | View source ↗ | MarketBeat | Sep 30, 2026 | neutral | 0 | 0.6 |
| AXGN | Axogen, Inc. Common Stock Financials - Revenue Breakdown - Quiver Quantitative | AXGN | Axogen, Inc. Common Stock Financials - Revenue Breakdown Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 23, 2026 | neutral | 0 | 0.6 |
| Axogen: The Regulatory Moat Is Becoming A Commercial Flywheel (NASDAQ:AXGN) - Seeking Alpha | Axogen: The Regulatory Moat Is Becoming A Commercial Flywheel (NASDAQ:AXGN) Seeking Alpha | View source ↗ | Seeking Alpha | Aug 3, 2026 | neutral | 0 | 0.6 |
| Axogen (AXGN) Stock Faces Margin Squeeze Despite Strong Revenue Growth - Simply Wall Street | Axogen (AXGN) Stock Faces Margin Squeeze Despite Strong Revenue Growth Simply Wall Street | View source ↗ | Simply Wall Street | Jul 30, 2026 | neutral | 0 | 0.6 |
| Axogen (NASDAQ:AXGN) Shares Slide After Q2 Earnings Miss Overshadows Revenue Beat and Raised Guidance - ChartMill | Axogen (NASDAQ:AXGN) Shares Slide After Q2 Earnings Miss Overshadows Revenue Beat and Raised Guidance ChartMill | View source ↗ | ChartMill | Jul 29, 2026 | neutral | 0 | 0.6 |
| AXGN Forecast — Price Target — Prediction for 2027 - TradingView | AXGN Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Axogen (AXGN) Stock After 314% One-Year Surge Is The Rally Losing Steam? - Simply Wall Street | Axogen (AXGN) Stock After 314% One-Year Surge Is The Rally Losing Steam? Simply Wall Street | View source ↗ | Simply Wall Street | Jun 25, 2026 | neutral | 0 | 0.6 |
| Axogen, Stock Of The Day, Offers Entry After Bullish Rebound - Investor's Business Daily | Axogen, Stock Of The Day, Offers Entry After Bullish Rebound Investor's Business Daily | View source ↗ | Investor's Business Daily | Jun 5, 2026 | neutral | 0 | 0.6 |
| AXGN Stock Climbs As Analysts Hike Price Targets On Coverage Wins - timothysykes.com | AXGN Stock Climbs As Analysts Hike Price Targets On Coverage Wins timothysykes.com | View source ↗ | timothysykes.com | Apr 28, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.